Olvi-Vec Combined With Platinum Plus Etoposide Therapy in Patients With Late Phase SCLC
Clinical trial NCT07136285 · RECRUITING
Trial details
- NCT number
- NCT07136285
- Sponsor
- Newsoara HYK Biopharmaceutical (Shanghai) Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-24
- Primary completion
- 2026-12-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.